TRAW: Traws Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.77
Enterprise Value ($M) 103.50
Book Value ($M) 6.10
Book Value / Share 3.34
Price / Book 1.44
NCAV ($M) 6.08
NCAV / Share 3.33
Price / NCAV 1.44

Profitability (mra)
Return on Invested Capital (ROIC) -22.47
Return on Assets (ROA) -5.07
Return on Equity (ROE) -9.44

Liquidity (mrq)
Quick Ratio 1.87
Current Ratio 1.88

Balance Sheet (mrq) ($M)
Current Assets 18.67
Assets 18.69
Liabilities 12.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
09-23 13D Orbimed Advisors Llc 19.90
04-08 13D Viriom, Inc. 11.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-09 2,509 9,695 25.88
2024-10-08 2,440 11,478 21.26
2024-10-07 9,045 35,014 25.83
2024-10-04 1,876 5,202 36.06

(click for more detail)

Similar Companies
TNFA – TNF Pharmaceuticals, Inc. TNXP – Tonix Pharmaceuticals Holding Corp.
TPST – Tempest Therapeutics, Inc. TTNP – Titan Pharmaceuticals, Inc.
UNCY – Unicycive Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io